Susquehanna International Group’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$303K Buy
+48,300
New +$449K ﹤0.01% 10829
2025
Q4
Sell
-31,100
Closed -$638K 13238
2025
Q3
$638K Buy
+31,100
New +$493K ﹤0.01% 8417
2025
Q2
Sell
-24,200
Closed -$210K 13434
2025
Q1
$210K Buy
+24,200
New +$148K ﹤0.01% 10835
2024
Q3
Sell
-10,100
Closed -$101K 12740
2024
Q2
$101K Buy
+10,100
New +$111K ﹤0.01% 11026
2023
Q2
Sell
-14,500
Closed -$212K 12836
2023
Q1
$212K Buy
+14,500
New +$243K ﹤0.01% 10471
2022
Q4
Sell
-29,500
Closed -$437K 13324
2022
Q3
$437K Buy
+29,500
New +$583K ﹤0.01% 8840
2022
Q2
Sell
-17,600
Closed -$664K 13640
2022
Q1
$664K Sell
17,600
-11,100
-39% -$491K ﹤0.01% 8222
2021
Q4
$1.78M Sell
28,700
-48,800
-63% -$3.7M ﹤0.01% 5780
2021
Q3
$6.63M Sell
77,500
-118,600
-60% -$7.44M ﹤0.01% 3487
2021
Q2
$12.1M Buy
196,100
+133,900
+215% +$6.81M ﹤0.01% 2646
2021
Q1
$3.03M Buy
62,200
+12,900
+26% +$622K ﹤0.01% 4923
2020
Q4
$1.54M Buy
+49,300
New +$1.21M ﹤0.01% 5691
2020
Q2
Sell
-74,000
Closed -$670K 10686
2020
Q1
$670K Buy
+74,000
New +$702K ﹤0.01% 6294
2019
Q4
Sell
-41,300
Closed -$598K 10375
2019
Q3
$598K Buy
41,300
+16,700
+68% +$258K ﹤0.01% 6880
2019
Q2
$399K Buy
+24,600
New +$332K ﹤0.01% 7743

Other funds holding OPRX

Susquehanna International Group's OPRX Position: Q1 2026 in Review

Susquehanna International Group reduced its OptimizeRx (OPRX) stake by 62% in Q1 2026, selling an estimated $171K and leaving 11,373 shares worth $71.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12500.

Susquehanna International Group first reported a position in OPRX in Q4 2018 and has held it in 16 quarters since. The position peaked at $2.95M in Q1 2023. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Susquehanna International Group held 11,373 shares of OptimizeRx worth $71.4K as of Q1 2026.
  • Susquehanna International Group sold 18,368 OptimizeRx shares in Q1 2026, an estimated $171K.
  • OptimizeRx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12500 holding.
  • Susquehanna International Group first reported a position in OptimizeRx in Q4 2018 and has held it in 16 quarters since.
  • Susquehanna International Group's OptimizeRx position peaked at $2.95M in Q1 2023.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.